Friday, February 26, 2021

Clinical Trial Supplies Market - Global Future Forecasts to 2025

 Expected Revenue Growth:


The clinical trial supplies market is projected to reach USD 2.5 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 7.8%. The increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations are the key factors driving the growth of this market.

Overview of This Study:

This study involved four major activities in estimating the current size of the clinical trial supplies market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059

Market Size Estimation:


Both top-down and bottom-up approaches were used to estimate and validate the total size of the market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry have been identified through extensive secondary research
# The revenues generated by leading players operating in the clinical trial supplies market have been determined through primary and secondary research
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Logistics services segment to dominate the clinical trial supplies market in 2020

Based on service, the clinical trial supplies market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions. The logistics services segment is expected to account for the largest share of this market in 2020, primarily due to the globalization of clinical trials and the increasing number of trials involving temperature-sensitive products.

Phase III segment to register the highest growth in the clinical trial supplies market, by phase

Based on phase, the clinical trial supplies market is segmented into phase I, phase II, phase III, phase IV, and BA/BE studies. The phase III segment is expected to account for the largest share of the clinical trial supplies market in 2020. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the fact that phase III trials are the most expensive, time-consuming, and difficult to design and run.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059

North America is the largest regional market for clinical trial supplies

The global clinical trial supplies market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. North America is the largest regional market for clinical trial supplies, followed by Europe. The large share of the North American market can primarily be attributed to the presence of well-established CROs and the high and growing R&D expenditure by pharmaceutical and biopharmaceutical companies in the region.

Global Leaders:

The prominent players operating in the global clinical trial supplies market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&M Movianto (US), KLIFO A/S (Denmark), and Thermo Fisher Scientific, Inc. (US).

Chiral Chromatography Column Market - Emerging Trends & Global Future Forecasts

 Expected Revenue Growth:


The chiral chromatography column marketsize is projected to reach USD 123 million by 2025 from an estimated USD 99 millionin 2020, at a CAGR of4.5% during the forecast period. Increasing R&D investments in the pharmaceutical and biotechnology industry is driving the growth of the market. Moreover, growth opportunities in emerging countries as well asthe emergence of green chemistry,is likely to provide opportunities forthe chiral chromatography column industry.

Global Industry Segmentation:

The pharmaceutical&biotechnology companies end-usersegment is expected to grow at the highest CAGR from 2020 to 2025.


Pharmaceutical and biotechnology companies are among the key end-users of chiral chromatography columns.Increasing R&D for therapeutic areas, such as cancer, HIV/AIDS, and immunodeficiency disorders, technological innovations in biotechnology research, increasing focus of pharmaceutical and biotechnology companies on extending their product pipeline, rising number of drug discovery and clinical trial projects, and patent expiry of blockbuster drugs and biomolecules are some of the key factors driving the growth of this segment during the forecast period. Additionally, the availability of government and corporate funding for biotechnology and pharmaceutical research, growth of the pharmaceutical industry, and the presence of stringent regulatory guidelines for drug development and safety are other key factors driving the growth of this segment.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225453435

The metal based segment is expected to grow at the highest CAGR in the chiral chromatography column industry during the forecast period.


The increasing use of HPLC columns in academic institutes as well as in industries where high pressure is employed is likely to drive the market for stainless steel columns in the coming years. Agilent offers the SEC-5 HPLC columns packed with silica particles and coated with a neutral hydrophilic layer, which decreases sample-column interactions and improves peak capacity and resolution. Other prominent players in this market include Thermo Fisher Scientific, Inc., and Merck KGaA.Therefore, the high demand of metal-based columns in the pharmaceutical industry isexpected to emerge as key revenue pockets for the metal-based columns in the chiral chromatography column market.

The prepacked column is expected to grow at the highest CAGR during the forecast period.

Prepacked/ready-to-use columns are prefilled with the stationary phase and can directly be attached to chromatographic systems. Prepacked columns exhibit minimal variations and are uniform in nature. These columns are used for early method development for optimizing column packing. These columns are widely used in industries due to their ability to run large amounts of samples on adaily basis. Due to this, prepacked columns dominate the chiral chromatography columns market.

Chromatography columns are critical factors to the successful separation of valuable molecules. Pharmaceutical and biotechnology companies are extending their offering of standard, custom, and prepacked columns from lab-scale to pilot and process-scale. Prepacked large-scale columns meet the needs of manufacturing with single-use technologies.

Global Leaders:

To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the chiral chromatography columnmarket.The major players in the chiral chromatography column industry are Agilent Technologies (US), Thermo Fisher Scientific(US), Waters Corporation(US), Daicel Corporation (Japan), Bio-Rad Laboratories(US), W.R.Grace & Co. (US), Merk Group(Germany), GL Sciencies(Japan), Perkin Elmer (US), Shimadzu Corporation (Japan), Sartorious Group (Germany), Cytiva(US), ES Industruies (US), and Phenomenex  (US)

These players are adopting various strategies to increase their share in the chiral chromatography columnmarket.Contracts & agreements,new product launches, investments and expansions and mergers have been a widely adopted strategy by the major players in the chiral chromatography columnindustry.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=225453435

Geographical Expansion:

North America is expected to be the largest market during the forecast period.

US and Canada are the major countries considered for the study of the chiral chromatography column market. North America has a diverse and well-established R&D infrastructure, with rapid adoption of chromatography techniques among end-user industries. North America accounted for the largest share of 37.3% of the chiral chromatography columns market in 2019. A number of factors, such as increasing drug development activities, the availability of government funding for life science R&D, high adoption of technologically advanced solutions, and a large number of ongoing clinical research studies are driving the growth of the North American chiral chromatography columns market.

Thursday, February 25, 2021

Laparoscopic Repair Surgery Market - Emerging Trends & Global Future Forecasts

 Major Growth Boosting Factors:


The rising adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and favorable reimbursement scenario in developed countries are the major factors driving the growth of this market.

The report analyzes and studies the patient population affected with hernia in the US, Canada, Germany, France, the UK, Italy, Spain, Japan, China, and India. Along with patient population, the report studies the adoption of open and laparoscopic hernia repair surgeries and the adoption of tack and glue applicators for mesh fixation.

Based on the type of hernia repair surgery, open hernia repair surgery accounted for the largest market share in 2017. Open hernia repair does not require any advanced equipment and takes 25% lesser time than laparoscopy. This makes open hernia repair more cost effective. Moreover, this type of surgery is preferred for hernias that have been present for a long period of time.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260433127


Based on the type of mesh fixator, glue applicators are expected to register the highest growth rate in the forecast period. The cost effectiveness, reduction in surgery time, and lower pain associated with glue fixation are driving the adoption of glue in hernia mesh fixation.

Geographical Growth Scenario:

The US accounted for the largest share of the hernia mesh repair surgery market in 2017. The large share of the US is attributed to the large patient population, increasing adoption of technologically advanced products, and presence of a well-established medical reimbursement policy in the country.

Global Leaders:

The major players in the hernia mesh repair surgery market profiled in this report are Medtronic (Ireland), Johnson & Johnson (US), B. Braun (Germany), C. R. Bard (US), and W.L. Gore (US).

Major Stakeholders of The Industry:

#
Manufacturers of hernia mesh and mesh fixators
# Raw material suppliers
# Market research and consulting firms
# Regulatory bodies
# Venture capitalists
# Hospitals

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=260433127


Medtronic (Ireland): Medtronic is a multinational medical technology company that manufactures and markets products for alleviating pain and restoring health. The company’s products are used by hospitals, clinics, third-party healthcare providers, distributors, and other institutions (including governmental healthcare programs and group purchasing organizations).

Johnson & Johnson (US): Johnson & Johnson offers hernia repair products through its subsidiary Ethicon. The hernia repair and fixation segment offers absorbable strap fixation devices; open absorbable strap fixation devices; polypropylene hernia systems and plugs; hernia mesh, including absorbable lightweight mesh, soft polypropylene mesh, polypropylene mesh, and woven mesh; tissue separating mesh, including flexible composite mesh, surgical mesh, ventral patches, and open flexible composite mesh devices; and biologic mesh, including tissue matrix and acellular hydrated dermis.

Pharmaceutical Excipients Market - Forthcoming Trends to Boost the Global Industry Revenue

 Recent Developments in the Global Pharmaceutical Excipients Manufacturing Market:


#
In April 2019, Colorcon, Inc. (US) signed an agreement with DuPont Nutrition and Biosciences (US) in order to enhance the current product portfolio of CR Alliance products.

# In February 2019, Associated British Foods plc (UK) signed an agreement with Indchem International (India) under which, Indchem will distribute Associated British Food’s functional lipid excipient product line in the Indian market.

# In January 2019, Croda International (UK) acquired Brenntag Biosector (Denmark) for its vaccine adjuvants portfolio which would be complementary to Croda’s pharmaceutical excipients portfolio.

# In December 2018, Roquette Feres (France) signed an agreement with Thermo Fisher Scientific (US), which gives Thermo Fisher the right to distribute the product portfolio of Roquette in the US and Canada.

Expected Revenue Growth:

The pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=956

Key Questions Addressed in the Report:


# Who are the top 10 players operating in the pharmaceutical excipients market?
# What are the drivers, restraints, opportunities, and challenges in the pharmaceutical excipients market?
# What are the industry trends as well as the current scenario in the pharmaceutical excipients market?
# What are the growth trends in the pharmaceutical excipients market at the segmental and overall market levels?
# How is the pharmaceutical excipients market performing in different regions across the globe?

Market Share Estimation:

The market shares for leading pharmaceutical excipients manufacturing companies was arrived at after detailed assessment of their revenues from the pharmaceutical excipients business by secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases revenue share was arrived at after detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with various industry experts.

The Asia Pacific is expected to be the fastest growing the market in 2019

In 2018, the Asia Pacific region was seen as the fastest growing region in the Pharmaceutical Excipients Manufacturing Market. The ease of doing business in the Asia Pacific region in terms of reduced regulatory stringency, reduced raw material & labor costs, and a higher target market make this region the fastest growing market in 2019.

Data Triangulation:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=956

Global Leaders:


DuPont de Nemours, Inc. (US) and Roquette Feres (France) dominated the global pharmaceutical excipients market in 2018. The prominent players in the global pharmaceutical excipients market are Ashland Global Holdings, Inc. (US), BASF SE (Germany), Evonik Industries AG (Germany), Associated British Foods plc (UK), Archer Daniels Midland Company (US), Lubrizol Corporation(US), and Croda International (UK). Other players in this market are Innophos Holdings (US), Kerry Group plc (Ireland), WACKER Chemie AG (Germany), Colorcon, Inc. (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France).

Wednesday, February 24, 2021

Major Revenue Surge is Expected in the Global Human Microbiome Market by 2027

Overview of This Research Study:


The study involved two major activities in estimating the current market size of the Human Microbiome Research Market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Expected Revenue Surge

The global  human microbiome market is projected to reach USD 1,731 million in 2027 from USD 942 million in 2024, at CAGR of 22.5 % during the forecast period.

Major Growth Influencing Factors:

Market growth is largely driven by the increasing focus on the development of human microbiome therapy. It has also become a validated target for drug development. The growing number of collaborations between market players is expected to offer a wide range of growth opportunities for market players during the forecast period. However, a lack of expertise and detailed research on the human microbiome is restraining the growth of this market.

Download PDF Brochure@ 

Industry Segmentation:

The probiotics segment to account for the largest share of the global human microbiome market in 2022

Based on product, the Human Microbiome Research Market is segmented into probiotics, prebiotics, foods, medical foods, diagnostic tests, and drugs. The probiotics segment is expected to account for the largest share of the human microbiome market in 2022. The increasing awareness of probiotics for the prevention and treatment of various lifestyle & chronic diseases and health benefits of probiotics over conventional medicines, such as antibiotics are some of the major factors driving the growth of this segment.

The therapeutics segment to account for the largest share of the market in 2022

Based on application, the human microbiome market is segmented into therapeutics and diagnostics. The therapeutics segment is expected to dominate the market in 2022. This is due to the need for the development of reliable, precise, and quicker treatment of chronic lifestyle diseases and various other disorders.

The infectious diseases segment to account for the largest share of the market in 2022

Based on disease, the human microbiome market is segmented into five categories—infectious diseases, endocrine & metabolic disorders, inflammatory diseases, cancer, and other diseases. The infectious disease segment is expected to dominate the market in 2022. This is due to the increasing research in microbiome-based products and their use in treating infectious diseases. Many smaller companies are investing in research, and their major focus is on developing products targeting microbiome modulators for infectious diseases.

Recent Developments:

# In 2019, Seres collaborated with AstraZeneca to get a better understanding of the microbiome in augmenting the efficacy of cancer immunotherapy, including potential synergy with AstraZeneca compounds.

# In 2018, Enterome entered into a co-development and co-promotion agreement with Takeda for its investigational drug candidate EB8018. This drug is used in patients with Crohn's disease and has the potential to expand its use to other gastrointestinal (GI) disorders and liver diseases.

# In  2016, 4D Pharma acquired the production assets of Instituto Biomar to expand its clinical and production capabilities of live biotherapeutics.

Request Sample Pages@ 

Geographical Growth Expansion:

Europe to account for the largest share of the human microbiome market in 2022

On the basis of region, the global Human Microbiome Research Market is segmented into four major geographies— North America, Europe, the Asia Pacific, and the Rest of the World (RoW). Europe is expected to account for the largest share of the global human microbiome market in 2022. The large share of this regional segment is mainly due to the high research activity in this region.

Key questions addressed by the report:

# Who are the major market players in the human microbiome market?
# What are the regional growth trends and the largest revenue-generating regions for the market?
# What are the major drivers and challenges in the market?
# What are the major product segments in the market?
# What are the major technologies used in the human microbiome research spending market?

Global Key Players:

The major players in the human microbiome market include Enterome Bioscience (France), 4D Pharma (UK), and Seres Therapeutics (US).

Read the Detailed Article@ 

ePrescribing Market - Emerging Industry Trends to Boost the Global Revenue

Market Size Estimation:


The total market size for the ePrescribing Mechanism Market was arrived at after data triangulation from two different approaches, as mentioned below.

Approach 1: Parent Market Analysis

In this report, the global market size for the Revenues of individual companies providing EHR solutions with the integrated e-prescribing module was gathered from public sources and databases. Shares of the EHR market provided by leading players were gathered from secondary sources to the extent available.  Individual shares or revenue estimates were validated through expert interviews.

Approach 2: Demand Side Analysis

In the case of demand-side analysis, the total number of physicians utilizing the e-prescribing module was studied using secondary and primary research. All the responses were collated to derive a probabilistic estimate of the market size based on the annual and implementation costs per physician per year.

Download PDF Brochure@ 

Expected Revenue Research:

The global ePrescribing market size is projected to reach USD 3.3 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 23.3%.

Major Growth Boosting Factors:

Factors such as the increasing adoption of EHR solutions, government initiatives and incentive programs, rising focus on reducing the abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail the escalating healthcare costs are driving the growth of the e-prescribing market. Additionally, the onset of the COVID-19 pandemic has accelerated the use of telemedicine modules and telehealth consultations. This is further driving the adoption of e-prescribing solutions.

Research Methodologies Followed for This Research:

Secondary Research:

Various secondary sources such as the World Health Organization (WHO), Healthcare Information and Management Systems Society (HIMSS), National Association of Healthcare Quality, California Association of Public Hospitals and Health Systems (CAPH), Centers for Medicare and Medicaid Services (CMS), RAND Europe, Australian Digital Health Agency, annual reports/SEC filings as well as investor presentations and press releases of key players have been used to identify and collect information useful for the study of this market.

Primary Research:

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. The primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors, and key opinion leaders. Primary sources from the demand side include personnel from hospitals, ambulatory care centers, clinics, and pharmacies.

Request Sample Pages@ 

Aftereffects of COVID19:

Due to lockdown restrictions and social distancing protocols due to COVID-19 across various countries through the first half of 2020, the market saw an increase in the number of telehealth consultations followed by use of eprescribing solutions to prescribe medicines.  Additionally, governments across countries are trying to regulate and expedite the use of ePrescribng functionality with telehealth functionality to avoid unnecessary hospital visits. Hence, the market is expected to show a slight increase in size due to increased adoption of these solutions.

Geographical Growth Survey:

North America will continue to dominate the ePrescribing market in 2025

In 2019, the large share of this North American region can be attributed to the stringent legislative and accreditation requirements regarding healthcare, high adoption of HCIT technologies, regulatory requirements regarding patient safety, and the presence of a large number of e-prescribing solution providers in the region.

Key Players:

Prominent players in the global ePrescribing Mechanism Market are Epic Systems Corporation (US), Cerner Corporation (US), Allscripts (US), NextGen Healthcare (US), athenahealth, Inc. (US), RelayHealth, LLC (US), Henry Schein, Inc. (US), GE Healthcare (US), Computer Programs and Systems Inc. (US), DrFirst, Inc. (US), Surescripts-RxHub, LLC (US), and Medical Information Technology, Inc. (US).

Read the Detailed Article@ 

Tuesday, February 23, 2021

Care Management Solutions Market - Emerging Innovations to Bring Major Revolutions in Global Market

 Market Dynamics:


Major Growth Driver: Implementation of initiatives to shift the burden of risk from healthcare payers to providers


Globally, various initiatives are being implemented to shift the burden of risk borne by healthcare payers to providers. This shift promotes the adoption of healthcare information technology (HCIT) solutions (such as care management solutions) to increase the efficiency of healthcare delivered and reduce unnecessary costs. For instance, in 2015, Medicare applied the Value-based Payment Modifier program to payments under the Medicare Physician Fee Schedule (PFS) for physicians in groups of 100 or more eligible practitioners. 

The Value-based Payment Modifier program offers differential payment to a physician or group of physicians based on the quality of care furnished instead of the cost of care. Value-based care is also promoted through alternative payment models such as bundled payments, physician incentives, and consumer incentives, among others. These models of payment are designed to encourage healthcare providers to accept the accountability of care delivered, thus leading to the shift of risk from payers to providers.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19482811


Healthcare organizations across the globe are aiming to provide coordinated, comprehensive care across the continuum to ensure patient satisfaction and improve overall health outcomes. As care management solutions aid stakeholders in the healthcare sector to achieve this objective, their adoption is expected to increase in the coming years.

Opportunity: Emerging markets

In Asia and Australasia, the rollout of public healthcare programs combined with growing consumer wealth is anticipated to boost healthcare spending at an average of 8.1% from 2014 to 2018 (Source: The Economist Intelligence Unit). Government initiatives for the implementation of HCIT solutions, rise in government spending on healthcare systems, and the presence of skilled IT experts are favoring the growth of the care management solutions market in the Asia Pacific region.

Expected Growth in Revenue During Forecast Period:

The global care management solutions market is projected to reach USD 19.28 billion by 2023 from USD 9.15 billion in 2018, at a CAGR of 16.1% during the forecast period.

Recent Developments in the Global Market:

#
February 2016, ZeOmega partnered with Vivify Health, Inc. (US) to integrate ZeOmega’s Jiva platform with Vivify mobility applications

# In 2016 EXL Service Holdings, Inc. partnered with Novu LLC, to develop solutions to enhance consumer satisfaction and reduce costs for payers and providers.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=19482811

By end user, the payers segment is expected to command the largest share of the market in 2018


On the basis of end user, the market has been segmented into payers, providers, and other end users. The payers segment is expected to command the largest share of the market in 2018. The deployment of care management solutions is increasing among payers as it helps them in the effective management of patient health records, claims processing and reimbursement tasks, coordinating care for their members, and ensuring better health outcomes to mitigate their risk burden. The growing stringency ofregulations for payers is another important factor driving the adoption of care management solutions in this end-user segment.

North America to dominate the market in 2018

North America is expected to account for the largest share of the care management solutions market in 2018, followed by Europe. The large share of North America can be attributed to the increased adoption of care management solutions by healthcare providers and payers to meet the healthcare goals of better quality care and lower healthcare costs. Also, several major global players are based in the US, owing to which the US has become a center for innovation in the care management solutions market.

Global Leaders:

The care management market is rapidly emerging with many regional as well as international players. In 2017, the care management solutions market was dominated by a few large players, namely, EXL Service Holdings, Inc. (US), Casenet, LLC (US), Medecision Inc. (US), ZeOmega Inc. (US), Cognizant Technology Solutions (US), Cerner Corporation (US), Allscripts Healthcare Solutions, Inc. (US), and TCS Healthcare Technologies (US).

Product deployments and launches, acquisitions, partnerships, agreements, and collaborations were strategies adopted by key players between 2015 and 2018 to enhance their share in the care management market. Important players that adopted these strategies include EXL Service Holdings, Inc. (US), Casenet, LLC (US), Medecision Inc. (US), ZeOmega Inc. (US), Cognizant Technology Solutions (US), Cerner Corporation (US), Allscripts Healthcare Solutions, Inc. (US), and TCS Healthcare Technologies (US).

Read the Detailed Research Report@ 
https://www.marketsandmarkets.com/Market-Reports/care-management-solutions-market-19482811.html

Topical Drug Delivery Market - Emerging Trends to Boost the Global Industry Revenue

 Current Situation: COVID-19 Impact on Global Topical Drug Delivery Market


According to our findings, the Topical Drug Delivery Procedure Market is expected to grow at an approximate CAGR of 6-7% during the next two years. According to our analysis, the below factors are playing a key role in shaping the growth of the global market.

# The number of COVID-19 cases has been increasing at an alarming rate in the US. The need for improved patient care and the adoption of drugs such as vitamin C, multivitamins, and antivirals, to improve immunity levels, have surged as a result.

# Due to the rapid spread of COVID-19 and increasing fear, drugs are being stocked by various end users and patients. This is expected to boost the growth of the topical drug delivery market from 2020–2021. Various companies have witnessed an increase in revenue in Q1 2020 as compared to Q1 2019. For example, AbbVie reported an increase of 16.8% in its revenue during this period. Similarly, Amgen recorded a revenue of USD 6,161 million in Q1 2020, an 11% increase as compared to Q1 2019 (USD 5,286 million).

# Raw materials required for manufacturing drugs (such as drug components, equipment used in manufacturing) are at the risk of a supply shortage due to the temporary lockdown of manufacturing sites in areas affected by COVID-19 or travel restrictions impacting shipments.

# The normalization of the global economy is expected to proceed slowly, with a gradual increase in the manufacturing and transportation of raw materials and associated equipment; this will lead to market growth from Q1 2021.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124871717

Major Growth Driver: High prevalence of skin diseases


According to the Global Burden of Disease Project, skin diseases such as psoriasis, eczema, skin cancer, and vitiligo continue to be the fourth-leading cause of nonfatal disease burden worldwide and affect a large proportion of the global population. According to the WHO, between 2 and 3 million cases of non-melanoma skin cancer and 132,000 cases of melanoma skin cancer are diagnosed annually across the globe. Furthermore, the prevalence of psoriasis worldwide ranges between 0.09% and 11.43%, making it a serious global problem with at least 100 million individuals affected worldwide (Source: WHO 2016). As topical drug delivery is the first line of treatment for the majority of skin diseases, the demand for advanced topical products is expected to increase in the coming years.

Market Size Estimation:

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, route of administration, facility of use, and region).

Expected Revenue Surge in Forecast Period:

The topical drug delivery market is projected to reach USD 129.8 billion by 2025 from USD 95.2 billion in 2020, at a CAGR of 6.4% during the forecast period.

Data Triangulation:

After arriving at the market size, the total topical drug delivery market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=124871717

Recent Developments in the Industry:


# In 2019, Mylan launched its DICLOFENAC SODIUM Gel.

# In 2019, Nestlé Skin Health opened a new office in Malaysia to accelerate growth in the Southeast Asian market.

# In 2019, Crescita Therapeutics signed an out-licensing agreement with Cantabria labs for the sales and distribution of its topical Pliaglis formulation in Italy, Portugal, France, and Spain.

# In 2018, Bausch Healthcare expanded its manufacturing facility in Rochester (Ireland) in order to support and fulfill the demand of its topical eye health products.

North America is expected to hold the largest share for players operating in the topical drug delivery market

North America accounted for the largest share of the Topical Drug Delivery Procedure Market in 2019. Factors such as presence of a highly developed healthcare system and a large number of topical drug-manufacturing companies in the country are among the few factors expected to contribute to the growth of this market. Furthermore, the growing geriatric population in the US, high disposable incomes, increasing preference for pain-free drug delivery solutions, and the availability of advanced and effective technology are driving market growth in North America.

Global Leaders:

The prominent players in Topical Drug Delivery Market are Johnson & Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), and Bayer AG (Germany).

Read the Detailed Report@ 
https://www.marketsandmarkets.com/Market-Reports/topical-drug-delivery-market-124871717.html

Monday, February 22, 2021

Healthcare IT Market worth $390.7 billion by 2024

 Expected Revenue Growth:


The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period. The demand for healthcare IT solutions and services is driven by government mandates & support for healthcare IT solutions, rising use of big data in healthcare, high returns on investment for healthcare IT solutions, and the need to curtail escalating healthcare costs.

“The healthcare provider solutions segment is estimated to grow at the highest CAGR during the forecast period”

The healthcare provider solutions segment is estimated to witness the highest growth in the Healthcare IT market, by product and services, during the forecast period. Growth in this segment is attributed to the increasing demand for improved patient safety and patient care, stringent regulations regarding healthcare provider solutions, and the need for integrated healthcare systems.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252

“The healthcare payer fraud detection analytics market is estimated to witness high growth from 2019 to 2024”


Based on healthcare payers solutions, the market is segmented into claims management, customer relationship management, payer fraud analytics solutions, provider network management, pharmacy audit & analysis, member eligibility management, population health management solutions, and payment management solutions. The fraud analytics solutions is estimated to witness high growth from 2019 to 2024. The growing incidence of healthcare fraud (leading to the increasing healthcare costs and rising insurance premiums) has compelled payers and other stakeholders in the market to increase their focus on adopting data analytics software for faster and efficient fraud detection and prevention.

“North America dominated the Healthcare IT market in 2018”

The Healthcare IT market is broadly segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Healthcare IT market in 2018. The large share of this region can be attributed to the technological competencies of healthcare industry and presence of well-established healthcare IT infrastructure in this regions. Changing regulatory requirements for improving quality of healthcare and increasing patient safety and rising healthcare expenditures are some of the key factors driving the growth of the healthcare IT market in North America.

Global Leaders:

Some of the major players operating in this market include Optum (US), Cerner (US), Cognizant (US), Change Healthcare (US), Philips Healthcare (Netherlands), Epic Systems (US), Dell Technologies (US), Allscripts (US), GE Healthcare (US), IBM (US), Athenahealth (US), Oracle Corporation (US), COnduent (US), Infor (US), Tata Consultancy Services (India), Wipro Limited (India), Conifer Health (US), Nuance (US), 3M (US), Inovalon (US), InterSystems (US), Leidos (US), Softheon (US), Omnicell (US), and Ciox Health (US).

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=252

Patient Blood Management Market – Market Penetration Opportunities in Developing Countries

 Major Growth Boosting Factors:


Globally, the demand for donated blood is increasing because of greater volume of sophisticated medical surgical procedures conducted and the increasing number of trauma cases due to road accidents. These procedures require blood transfusions to make up for blood loss incurred during the procedures. Thus, the rising number of accidents, trauma cases, and surgical procedures performed are contributing to the market growth, thereby increasing the need for patient blood management products.

Expected Revenue Growth:

The patient blood management market is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024.

Overview of This Research:

The study involved four major activities to estimate the current size of the patient blood management market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.

Download PDF Brochure@ 

Market Size Estimation:

A detailed market estimation approach was followed to estimate and validate the size of the patient blood management market and other dependent submarkets, as mentioned above. The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the market.

All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources. All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report. The research methodology used to estimate the market size includes the following:

Product mapping of various manufacturers for each product type of patient blood management at the regional and/or country level.

Relative adoption pattern of each patient blood management system among key end users at the regional and/or country level.

Detailed primary research to gather quantitative information related to segments and subsegments at the region and/or country-level.

Detailed secondary research to gauge prevailing market trends at the region and/or country-level

Blood banks were the key end users in the patient blood management market in 2019

On the basis of end users, the patient blood management market is segmented into hospitals and blood banks. The increasing number of blood donations has increased the need for proper management of blood. Blood banks are the key end users for various blood processing devices, blood collection devices, and blood storage devices. The key factors attributing to the growth of the blood banks segment include the growing awareness about blood donations, rising automation in blood banks, and the increase in the number of blood banks in developing countries.

Data Triangulation:

After arriving at the overall market size of the patient blood management industry from the market estimation approach explained above, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact market value data, data triangulation, and market breakdown methodology methods were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand- and supply-side analysis.

Request Sample Pages@ 

Geographical Growth:

The Asia Pacific region is expected to register significant growth during the forecast period of 2019-2024

The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific blood management market is expected to register significant growth over the forecast period due to the modernization of healthcare infrastructure, increasing prevalence of chronic lifestyle diseases, and rising awareness about blood donation & blood safety. China accounted for a major share of the Asia Pacific market, owing to a large patient pool and favorable government guidelines to improve healthcare infrastructure in the country.

Global Leaders:

The major players in the market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche LTD (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc. (Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.

Growth Strategies Adopted by Global Leaders:

An analysis of market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, collaborations, partnerships, agreements, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the patient blood management market.

Read More Detailed Article@ 

Friday, February 19, 2021

North American Healthcare IT Market worth $239.9 billion by 2025

 Overview of This Research Study:


The study involved four major activities in estimating the size of the North America healthcare IT market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their trends at the country level. Industry experts further validated the data obtained through secondary research through primary research. Furthermore, the market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (country-level incidence data for various diseases) and top-down approach (assessment of utilization/adoption/penetration trends, by product and services, components, and end user). After that, market breakdown and data triangulation methods were used to estimate the size of segments and subsegments.

Secondary Research:

Various secondary sources such as the US Department of Health and Human Services, Healthcare Information and Management Systems Society (HIMSS), National Association of Healthcare Quality, Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services (CMS), US Department of Labor, The Agency for Healthcare Research and Quality (AHRQ), Medical Records Institute, General Physician Hospital Organization (GPHO), Association of Information and Image Management (AIIM), The Economist Intelligence Unit, American Health Information Management Association (AHIMA), Healthcare IT News, World Health Organization (WHO), annual reports/SEC filings as well as investor presentations and press releases of key players have been used to identify and collect information useful for the study of the North America healthcare IT market.

Primary Research:

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. The primary participants mainly include product managers, business development directors, sales managers, and healthcare providers across the industry.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1190

Major Revenue Growth Boosters:

The North America healthcare IT market size is projected to reach USD 239.9 billion by 2025 from USD 96.3 billion in 2019, at a CAGR of 16.4% during the forecast period. Market growth can be attributed to the growing need to adhere to regulatory guidelines, government initiatives for eHealth, high return on investment (ROI), and rising need to curtail the escalating healthcare costs. However, the lack of in-house IT knowledge and reluctance among end-users to adopt new methods are expected to restrain the overall market growth to a certain extent during the forecast period.

Based on products and services, the healthcare providers segment accounted for the largest share of the North America healthcare IT market in 2018

Based on the products and services, the healthcare providers segment accounted for the largest share of the North American healthcare IT market in 2018. The large share of this segment is mainly attributed to the rising adoption of EHRs and other hospital information systems by healthcare providers, the inclination of the healthcare industry towards deployment of interoperable solutions, and growing regulatory requirements regarding patient information and safety. In this report, the healthcare provider solutions segment is segmented further into clinical solutions and non-clinical solutions. EHR, mHealth solutions, and PACS & VNA are some of the key clinical healthcare IT solutions covered in this report.

Recent Developments:

# In 2019, Cerner Corporation launched the Next-generation cognitive health platform.
# In 2019, GE Healthcare launched Edison Datalogue and my.Cryochain software.
# In 2019, Cerner Corporation collaborated with Uniform Data System for Medical Rehabilitation to integrate their solutions that would help improve workflow for inpatient rehabilitation facilities.
# In 2019, Epic Systems partnered with Teledoc Health to integrate Teledoc Health’s virtual care platform to Epic’s App Orchard that would help the company conduct telehealth video visits.

By components, the services segment accounted for the largest share of the North America healthcare IT market in 2018

Based on components, the market is segmented into services, software, and hardware. In 2018, the services segment accounted for the largest share of the North American healthcare IT market. This is attributed to the introduction of complex software, the need for integration and interoperability of software, and the growing demand for consulting and outsourcing of various healthcare processes such as revenue cycle management, EHR management, pharmacy information management, and fraud detection.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1190

Key Questions Addressed in the Report:

#
Who are the top 10 players operating in the global North America healthcare IT market?
# What covers the drivers, restraints, opportunities, and challenges in the North America healthcare IT industry?
# What are the new technological advancements in the North America healthcare IT market?
# Comment on the regulatory scenario for the North America healthcare IT industry in various geographies.
# What are the growth trends in the North America healthcare IT market at the segmental and overall market levels?

By end-users, the healthcare providers segment accounted for the largest share of the North America healthcare IT market in 2018

Based on end-users, the North American healthcare IT market is segmented into healthcare providers and healthcare payers. The healthcare providers segment is divided further into hospitals; ambulatory care centers; home healthcare agencies, nursing homes, and assisted living facilities; diagnostic and imaging centers; and pharmacies.

The healthcare payers segment is divided further into private payers and public payers. Hospitals form the largest end-user segment of the North American healthcare IT market, owing to the huge demand for various HCIT solutions among hospitals to manage the increasing load of patient information generated in hospitals and growing need to improve the quality of healthcare while improving operational efficiencies within organizations.

Global Leaders:

Some of the prominent players operating in the North America healthcare IT market are McKesson Corporation (US), Oracle Corporation (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Athenahealth, Inc. (US), Infor, Inc. (US), Cognizant (US), Dell Technologies (US), and CVS Health (US).

Read the Detailed Article@ 
https://www.marketsandmarkets.com/Market-Reports/north-america-healthcare-it-market-1190.html

This is How Leading Players in the Surgical Imaging Market are Trying to Retain Their Places, Globally..!

 Global Leaders:


GE Healthcare (UK), Siemens AG (Germany), Koninklijke Philips (Netherlands), and Ziehm Imaging (Germany) are considered to be the leading players in the surgical imaging market.

Overview of This Study:

This study involved four major activities in estimating the size of the surgical imaging market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Expected Revenue Growth:

The global surgical imaging market is projected to reach USD 2.4 billion by 2025 from an estimated USD 1.8 billion in 2020, at a CAGR of 6.3% during the forecast period. The major factors driving the growth of this market include the advantages of FPDs over image intensifiers, technological advancements, reimbursement cuts for analog radiography systems, and the increasing demand for minimally invasive procedures. However, the high cost of systems is estimated to restrain the growth of this market during the forecast period.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210534462

GE Healthcare
held the leading position in the global surgical imaging market in 2019. Its leading position in this market is attributed to the highest number of installed systems—with around 35,000 C-arms installed globally—and its wide and diverse mobile C-arm offerings. The strong, wide, and diversified portfolio of mobile C-arms is an asset to the company. Some of the biggest advantages that GE Healthcare has over its competitors are its diverse product portfolio and strong customer base (to which GE can upsell products and offer bundled services).

Siemens Healthineers held the second-leading position in the market in 2019. The firm maintains its position in the market by offering eight mobile C-arms. Cios Alpha is the company’s flagship mobile C-arm that delivers excellent image quality at low dosages. The company also focuses on expanding its presence in emerging markets (such as India). For this, the company has lowered its production costs and is delivering price-competitive products in emerging markets. Siemens Healthineers has a powerful brand image, strong product portfolio, and vast geographical presence. All these factors enable the company to retain its position as a prominent player in the surgical imaging market.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the surgical imaging market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Philips is another leading player in the surgical imaging market. The company has a strong product portfolio comprising a variety of mobile C-arm platforms that it offers under its Image-guided Therapies (IGT) segment. The IGT segment of Philips has shown strong growth in the past couple of years due to aggressive expansion in emerging markets, strong product portfolio, and strong focus on innovation. The revenues increased by 10.5% between 2017 and 2019. A strong product portfolio and focus on innovation, coupled with aggressive expansion in Asia, is enabling the company to be a prominent player in the surgical imaging market.

Ziehm Imaging occupies the fourth position in the surgical imaging market. The company has over 40 years of experience in this market. Ziehm is recognized as a technological leader in the mobile C-arms segment. The company invests around 15% of its revenue in R&D. Also, a major part of its product portfolio is younger than 3 years. Ziehm Imaging was the first company to launch the flat-panel technology in the market and was the first company to launch a mobile C-arm with the motorization of all 4 axes.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=210534462

The Hospital end user segment to account for the largest share during the forecast period


Based on end users, the market is divided into hospitals and surgery centers. Hospitals are expected to account for the largest share of the surgical imaging market in 2020, while surgery centers are expected to account for the highest growth rate. The large share of this segment can be attributed to  the rising demand for effective disease management, growing surgical procedural volumes in hospitals, and the increasing number of hospitals being set up in developing countries.

North America regional segment to account for the largest market share of the surgical imaging market

Geographically, the surgical imaging market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. North America is the largest regional market for surgical imaging systems, followed by Europe. The large share of the North American market can be attributed to the significant growth in hospital expenditure, the increasing incidence of overuse sports injuries, rising prevalence of CVD, and the increasing number of hip and knee replacement surgeries in the region.

COVID-19 Impact on the Surgical Imaging Market

The COVID-19 outbreak has upended many lives and businesses on an unprecedented scale. The pandemic is going to negatively impact the surgical imaging market. The pandemic has put significant strain on the healthcare systems of the world. During this period, healthcare institutions and providers have been instructed to stop performing elective surgical procedures and medical examinations to slow the spread of the disease and conserve healthcare resources for COVID-19 patients.

According to a report published by researchers of CovidSurg Collaborative, around 28 million surgeries were canceled across the globe during 12 weeks of peak disruption during the COVID-19 pandemic. . The American Hospital Association estimated an average loss of revenues to US hospitals of USD 50.7 billion per month from March 1 to June 30, 2020 due to loss of elective procedures (as these procedures typically constitute a substantial part of hospital revenue).

Read the Detailed Report@ 
https://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html

Thursday, February 18, 2021

Transdermal Drug Delivery System Market - Global Revenue Surge

 Major Growth Boosting Factors:


Market growth is largely driven by the global increase in the prevalence of chronic diseases. In addition, technological advancements in transdermal drug delivery systems are also expected to support market growth in the coming years.

Expected Revenue Growth:

The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period (2018-2023). 

The pain management segment is expected to account for the largest share of the market in 2018

On the basis of application, the market is segmented into pain management, central nervous system disorders, hormonal applications, cardiovascular diseases, and other applications (smoking cessation, motion sickness, and overactive bladder treatment). In 2018, the pain management segment is expected to account for the largest share of the transdermal drug delivery systems market. Growth in this market is largely driven by the high burden of chronic pain worldwide and the growing availability of transdermal products for pain management.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203190114

The transdermal patches segment is expected to grow at the highest CAGR during the forecast period


On the basis of type, the transdermal drug delivery systems market is segmented into transdermal patches and transdermal semisolids. In 2018, the transdermal patches segment is expected to account for the larger share of the transdermal drug delivery systems market. This drug delivery system offers several advantages, such as reduced dosing frequency, improved bioavailability, reduced adverse events, and drug input termination at any point by the removal of the patch. Also, the use of patches results in increased patient compliance due to their non-invasive nature and painless application. These factors are expected to drive market growth.

Recent Developments:

#
In January 2018, Hisamitsu Pharmaceutical (Japan) launched ALLESAGA TAPE in the Japanese market.
# In July 2018, UCB (Belgium) received the Import Drug License (IDL) for its transdermal rotigotine patch—NEUPRO from the China Food and Drug Administration (CFDA).
# In August 2018, Luye Pharma (China) signed an agreement with Bayer AG (Switzerland) to acquire the global rights to the Apleek contraceptive transdermal patch

North America to dominate the transdermal drug delivery systems market in 2018

North America is expected to dominate the transdermal drug delivery systems market in 2018. The large share of the North American transdermal drug delivery systems market can primarily be attributed to the rising prevalence of targeted diseases (such as chronic pain, central nervous system disorders, and cardiovascular diseases) in the region, the increasing use of contraceptives, and the increasing number of research activities related to transdermal drug delivery systems.

Key Questions addressed by the report:

#
Which are the key players in the market and how intense is the competition?
# Emerging countries have immense opportunities for the growth of transdermal drug delivery systems market, will this scenario continue?
# Which product market will dominate in future?
# What does the future look like for transdermal drug delivery systems?
# What are the challenges hindering the adoption of transdermal drug delivery systems?

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=203190114

Major Leaders of the Industry:


The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

ePrescribing Market - Future Growth Boosting Factors & Global Leaders

 Research Methodologies Followed for This Research:


Primary Research:


Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. The primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors, and key opinion leaders. Primary sources from the demand side include personnel from hospitals, ambulatory care centers, clinics, and pharmacies.

Secondary Research:

Various secondary sources such as the World Health Organization (WHO), Healthcare Information and Management Systems Society (HIMSS), National Association of Healthcare Quality, California Association of Public Hospitals and Health Systems (CAPH), Centers for Medicare and Medicaid Services (CMS), RAND Europe, Australian Digital Health Agency, annual reports/SEC filings as well as investor presentations and press releases of key players have been used to identify and collect information useful for the study of this market.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=910

Expected Revenue Growth:


The global ePrescribing market size is projected to reach USD 3.3 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 23.3%.

Major Growth Boosters:

Factors such as the increasing adoption of EHR solutions, government initiatives and incentive programs, rising focus on reducing the abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail the escalating healthcare costs are driving the growth of the e-prescribing market.

Market Size Estimation:

The total market size for the ePrescribing market was arrived at after data triangulation from two different approaches, as mentioned below:

Approach 1: Parent Market Analysis

In this report, the global market size for the Revenues of individual companies providing EHR solutions with the integrated e-prescribing module was gathered from public sources and databases. Shares of the EHR market provided by leading players were gathered from secondary sources to the extent available.  Individual shares or revenue estimates were validated through expert interviews 

Approach 2: Demand Side Analysis

In the case of demand-side analysis, the total number of physicians utilizing the e-prescribing module was studied using secondary and primary research. All the responses were collated to derive a probabilistic estimate of the market size based on the annual and implementation costs per physician per year.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=910

Opportunities: Increased adoption of integrated telehealth solutions due to COVID-19


Even before the onset of the global pandemic, players in the EHR market had started integrating the telehealth feature with their existing solutions, due to advantages offered by telehealth consultations such as increased patient engagement in remote monitoring and reduction in overhead costs. However, the adoption of this feature increased significantly during the COVID-19 crisis. 

North America will continue to dominate the ePrescribing market in 2025

In 2019, the large share of this North American region can be attributed to the stringent legislative and accreditation requirements regarding healthcare, high adoption of HCIT technologies, regulatory requirements regarding patient safety, and the presence of a large number of e-prescribing solution providers in the region.

Global Leaders:

Prominent players in the global e-prescribing market are Epic Systems Corporation (US), Cerner Corporation (US), Allscripts (US), NextGen Healthcare (US), athenahealth, Inc. (US), RelayHealth, LLC (US), Henry Schein, Inc. (US), GE Healthcare (US), Computer Programs and Systems Inc. (US), DrFirst, Inc. (US), Surescripts-RxHub, LLC (US), and Medical Information Technology, Inc. (US).

Read the Detailed Article@ 
https://www.marketsandmarkets.com/Market-Reports/e-prescription-systems-market-910.html

Wednesday, February 17, 2021

Brain Monitoring Market - Expected Revenue Growth by 2025

 The global brain monitoring market size is estimated to be USD 8.6 billion by 2025 from USD 6.3 billion in 2020, at a CAGR of 6.2%. The brain monitoring market is mainly driven by factors such as the increasing incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases, growth in the number of traumatic brain injuries, and growing applications of brain monitoring in clinical trials.


The devices segment accounted for the largest share of the brain monitoring market

By product, the global brain monitoring market is categorized into devices and accessories. The devices segment held the largest share of the brain monitoring market in 2019. This is mainly due to the rising incidence of neurological, neurodegenerative, psychotic, and sleep disorders, the need for early diagnosis, the availability of innovative portable and wearable home-based monitoring devices, and increasing patient awareness

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=909


Hospitals  accounted for the largest share of the end user segment of the brain monitoring market

Based on end-users, the global brain monitoring devices market is segmented into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end users. The hospital segment held the largest share of the global brain monitoring market in 2019. Brain monitoring is a complex process, requiring expensive and advanced devices and equipment that are mainly found in hospitals. Hospitals also see a considerably larger inflow of patients as compared to small clinics and other end users. Additionally, brain monitoring devices pose a considerable burden in terms of maintenance expenses on healthcare facilities; hospitals, more than other end-users, can bear such costs. Hence, brain monitoring devices are mostly used in hospitals, which consequently account for the largest share of this market segment.

Recent Developments:

# In 2018, GE Healthcare launched its SIGNA Premier 3.0T magnetic resonance imaging (MRI) system in Canada.

# In 2018, Philips collaborated with Samsung Electronics to connect Samsung’s ARTIK Smart IoT Platform to Philips’ HealthSuite Digital Platform. This addressed the growing need for connected health platforms that can safely access, share, and analyze information, helping health systems and providers achieve their goal of delivering better care to consumers.

# In 2017, Natus acquired the global Camino ICP monitoring product line, including its San Diego manufacturing facility, from Integra. The sale also included the US rights to Integra's fixed-pressure shunts, as well as US rights to Codman's DURAFORM dural graft implants, standard EVD catheters, and CSF collection systems.

# In 2017, Philips acquired Electrical Geodesics to expand its existing portfolio of imaging technologies and advanced informatics for neurological applications.

North America accounted for the largest share of the global brain monitoring market

North America, Europe, the Asia Pacific, and the Rest of the World. North America held the largest share of the global brain monitoring market in 2019, while the Asia Pacific is projected to be the fastest-growing region in the forecast period. The high growth rate of the market in the Asia Pacific region can be attributed to the availability of low-cost labor and skilled manpower, increase in disposable incomes, rising prevalence of neurodegenerative disorders, and increasing government emphasis on healthcare reforms in the region.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=909

Key Players:


Some of the leading players in the Brain Monitoring market include Natus Medical, Inc. (US), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), CAS Medical Systems, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Advanced Brain Monitoring (US), Masimo Corporation (US), Spiegelberg GmbH & Co. KG (Germany), Cadwell Industries (US), NeuroWave Systems, Inc. (US), Nonin Medical, Inc. (US), Integra LifeSciences Corporation (US), Neurosoft (Russia), and Rimed (US).